In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs. Dr. Scott
brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere
, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch. Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs.Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc.Dr. Scott received his medical degree from Glasgow University, Scotland.
We are pleased that Dr. Scott
has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year.